MIM
SPNE

MetLife Investment Management’s SeaSpine Holdings Corporation Common Stock SPNE Stock Holding History

MetLife Investment Management’s Portfolio SPNE Stock Details SPNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-16,710
Closed -$140K – 2862
2022
Q4 		$140K Hold
16,710
– – ﹤0.01% 2448
2022
Q3 		$94.9K Hold
16,710
– – ﹤0.01% 2695
2022
Q2 		$94.4K Hold
16,710
– – ﹤0.01% 2732
2022
Q1 		$203K Buy
16,710
+5,871
+54% +$71.5K ﹤0.01% 2346
2021
Q4 		$148K Hold
10,839
– – ﹤0.01% 2248
2021
Q3 		$170K Hold
10,839
– – ﹤0.01% 2190
2021
Q2 		$222K Hold
10,839
– – ﹤0.01% 2097
2021
Q1 		$189K Hold
10,839
– – ﹤0.01% 2090
2020
Q4 		$189K Hold
10,839
– – ﹤0.01% 2014
2020
Q3 		$155K Hold
10,839
– – ﹤0.01% 2009
2020
Q2 		$113K Buy
+10,839
New +$111K ﹤0.01% 2199
2019
Q1 		– Sell
-7,730
Closed -$141K – 2600
2018
Q4 		$141K Buy
+7,730
New +$131K ﹤0.01% 2113

MetLife Investment Management's SPNE Position: Q1 2023 in Review

MetLife Investment Management sold out of SeaSpine Holdings Corporation Common Stock (SPNE) in Q1 2023, closing a stake of 16,710 shares — an estimated $140K sold.

MetLife Investment Management first reported a position in SPNE in Q4 2018 and held it in 12 quarters. The position peaked at $222K in Q2 2021. 0 funds tracked by Wall St. Rank hold SPNE as of Q1 2023.

  • MetLife Investment Management reported no remaining SeaSpine Holdings Corporation Common Stock position as of Q1 2023 after selling out during the quarter.
  • MetLife Investment Management sold 16,710 SeaSpine Holdings Corporation Common Stock shares in Q1 2023, an estimated $140K.
  • MetLife Investment Management first reported a position in SeaSpine Holdings Corporation Common Stock in Q4 2018 and held it in 12 quarters.
  • MetLife Investment Management's SeaSpine Holdings Corporation Common Stock position peaked at $222K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held SeaSpine Holdings Corporation Common Stock as of Q1 2023.

Based on MetLife Investment Management's 13F filing for Q1 2023, filed 15 May 2023.